XoNovo Overview
- Founded
-
2013
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
XoNovo General Information
Description
Developer of technologies for the treatment of neurodegenerative diseases. The company engages in the development of small-molecule therapeutics for preventing the progressive loss of neuronal function across multiple neurodegenerative diseases, enabling physicians with selective modulation of autophagy and axonal transport machinery in neurons.
Contact Information
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- Ilan Ramon Street 2
- Ness Ziona
- Israel
XoNovo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Sep-2019 | Completed | Out of Business | |||
| 1. Accelerator/Incubator | 12-Jan-2015 | Completed | Startup |